中文 | English
Return
Total: 17 , 1/2
Show Home Prev Next End page: GO
Author:( Yongqian SHU)

1.Midian Cleft Lip: Progress in Classification and Treatment

Jiuli ZHAO ; Kaiyi SHU ; Yongqian WANG

Chinese Journal of Plastic Surgery 2021;37(8):944-948

2.Midian Cleft Lip: Progress in Classification and Treatment

Jiuli ZHAO ; Kaiyi SHU ; Yongqian WANG

Chinese Journal of Plastic Surgery 2021;37(8):944-948

3.Midian Cleft Lip: Progress in Classification and Treatment

Jiuli ZHAO ; Kaiyi SHU ; Yongqian WANG

Chinese Journal of Plastic Surgery 2021;37(8):944-948

4.Midian Cleft Lip: Progress in Classification and Treatment

Jiuli ZHAO ; Kaiyi SHU ; Yongqian WANG

Chinese Journal of Plastic Surgery 2021;37(8):944-948

5.Midian Cleft Lip: Progress in Classification and Treatment

Jiuli ZHAO ; Kaiyi SHU ; Yongqian WANG

Chinese Journal of Plastic Surgery 2021;37(8):944-948

6.Midian Cleft Lip: Progress in Classification and Treatment

Jiuli ZHAO ; Kaiyi SHU ; Yongqian WANG

Chinese Journal of Plastic Surgery 2021;37(8):944-948

7.Comparison of postoperative complications between four surgery models in elderly esophageal cancer patients

Qingqing DING ; Lei XUE ; Wenyin ZHOU ; Yibo XUE ; Xiao HAN ; Dandan YIN ; Yongqian SHU ; Jinhai TANG ; Qi CHEN ; Jinhua LUO

Chinese Journal of Geriatrics 2019;38(3):292-295

8.Epigenetic modifications and non-small cell lung cancer

Chenhui ZHAO ; Yongqian SHU

Journal of International Oncology 2015;(3):196-199

9.Effect of tumor length on clinicopathologied and prognosis of node-negative esophageal carcinoma patients

Mingwen SHAO ; Liang CHEN ; Hongxia LI ; Lan MA ; Yongqian SHU ; Lianke LIU

China Oncology 2014;(11):846-851

10.MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.

Tongshan WANG ; Gaoxia GE ; Yin DING ; Xin ZHOU ; Zebo HUANG ; Wei ZHU ; Yongqian SHU ; Ping LIU

Chinese Medical Journal 2014;127(12):2357-2362

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 17 , 1/2 Show Home Prev Next End page: GO